Trials / Completed
CompletedNCT03707821
Design Validation of Senofilcon A With New UV-blocking Additive
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 253 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
This is a 2-visit, multi-site, partially subject-masked, 2-arm parallel, controlled, randomized and dispensing trial. Subjects will be randomized to one of two study lenses for the entire duration of the study. The study lenses will be worn for a period of 2 weeks each in a bilateral fashion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | senofilcon A TEST Lens | JJVC Investigational Contact Lens |
| DEVICE | senofilcon A CONTROL Lens | Acuvue Oasys |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2018-11-01
- Completion
- 2018-11-01
- First posted
- 2018-10-16
- Last updated
- 2019-12-05
- Results posted
- 2019-12-05
Locations
10 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03707821. Inclusion in this directory is not an endorsement.